SCHEMBL27126987

SCHEMBL27126987

c1ccc2c(c1)ccc1c2oc2c(-c3cccc4c3oc3ccccc34)ccc(-c3ccc4ccc5cccc6ccc3c4c56)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.45
ARSA P15289 1/20 0.41
CDC25A P30304 1/20 0.41
CDC25C P30307 1/20 0.41
PRKDC P78527 5/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CB P42338 1/20 0.37
CYP1A2 P05177 7/20 0.35
ERBB2 P04626 1/20 0.35
FYN P06241 1/20 0.35
MAOA P21397 1/20 0.35
ACHE P22303 1/20 0.35
AHR P35869 1/20 0.35
CYP1A1 P04798 6/20 0.34
CYP1B1 Q16678 6/20 0.34
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
CYP3A4 P08684 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27127036 0.94 ARSA (0.38) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL27127041 0.94 ARSA (0.45) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL27126980 0.91 L3MBTL1 (0.40) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL27127056 0.91 ARSA (0.39) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL27126211 0.90 CYP1A2 (0.40) ARSACDC25ACDC25CPRKDCL3MBTL1
SCHEMBL27126291 0.90 CYP1A2 (0.40) ARSACDC25ACDC25CPRKDCL3MBTL1
SCHEMBL27127212 0.90 CYP1A2 (0.40) ARSACDC25ACDC25CPRKDCL3MBTL1
SCHEMBL9920829 0.89 ALOX5 (0.54) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL12380218 0.89 ALOX5 (0.54) ALOX5ARSACDC25ACDC25CPRKDC
SCHEMBL27126227 0.89 CYP1A2 (0.42) ARSACDC25ACDC25CPRKDCL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-02-29 US disclosed
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-02-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RPS12, TCF12, RRP12 ALOX5 4095/4885ARSA 1411/4885CDC25A 3107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.